<html>
  <head></head>
  <body>
    <div id="title">
      <h2>"Point in Time" Regulation Content</h2>
      <h4>
        <em> Pharmacy Operations and Drug Scheduling Act </em>
      </h4>
      <h3 style="line-height: 110%">Drug Schedules Regulation</h3>
      <h3>B.C. Reg. 9/98</h3>
    </div>
    <table cellpadding="3" cellspacing="0" class="tablestyle3">
      <tbody
        xmlns:act="http://www.gov.bc.ca/2013/legislation/act"
        xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table"
        xmlns:xlink="http://www.w3.org/1999/xlink"
      >
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Adenosine and its salts (for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c2" valign="top">1</td>
          <td colname="c2" valign="top">
            Adrenocortical hormones and their salts and derivatives
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
            , including, but not limited to, hydrocortisone, hydrocortisone
            acetate, hydrocortisone valerate, hydrocortisone sodium succinate,
            clobetasone butyrate, difluprednate, triamcinolone acetonide and
            fluticasone (except
            <br />
            (a) hydrocortisone or hydrocortisone acetate, when sold as a single
            medicinal ingredient in a concentration that provides 1% or less
            hydrocortisone in preparations for topical use on the skin,
            <br />
            (b) hydrocortisone or hydrocortisone acetate, when sold in
            combination with any other non-prescription medicinal ingredient
            that provides 1% or less hydrocortisone in preparations for topical
            use on the skin,
            <br />
            (c) clobetasone butyrate, when sold in a concentration of 0.05%
            clobetasone butyrate in cream preparations for topical use on the
            skin,
            <br />
            (d) triamcinolone acetonide in an aqueous nasal spray that delivers
            55 mcg per metered spray for adults and children 12 years of age and
            older, and
            <br />
            (e) fluticasone propionate, when sold for the treatment of allergic
            rhinitis in a nasal spray that delivers 50 mcg per metered spray for
            individuals 18 years of age and older)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Antipyrine (except preparations for topical or otic use)
            <a href="#footnote_V">
              <sup> V </sup>
            </a>
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Antipyrine for otic or topical use</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Apomorphine and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">1</td>
          <td colname="c2" valign="top">
            Cimetidine and its salts (except when sold in concentrations of
            100Â mg or less per unit dose)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Cimetidine and its salts when sold in concentrations of 100 mg or
            less per unit dose
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">Deoxycholic acid and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Dimenhydrinate and its salts (for oral use when sold in packages of
            greater than 30 dosage units or for parenteral use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Dimenhydrinate and its salts (for oral use when sold in packages of
            30 dosage units or less or for rectal use)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">Glycopyrrolate and its salts</td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Hyoscine and its salts and derivatives [scopolamine]
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Levonorgestrel when sold in concentrations of 0.75 mg per oral
            dosage unit (except when labelled to be taken as a single dose of
            1.5 mg and in package sizes containing no more than 1.5 mg
            levonorgestrel, packaged and labelled for emergency contraception)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Levonorgestrel (when sold in concentrations of 0.75 mg per oral
            dosage unit to be taken as a single dose of 1.5 mg, packaged and
            labelled for emergency contraception, in package sizes containing no
            more than 1.5 mg levonorgestrel)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Minoxidil foam for topical use in concentrations of 5% or less for
            androgenetic alopecia (male or female pattern baldness or hair loss)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Minoxidil in solutions for topical use in concentrations of 2% or
            less
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">3</td>
          <td colname="c2" valign="top">
            Phenylephrine hydrochloride for ophthalmic use in concentrations of
            2.5% or less
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Potassium salts (oral preparations containing more than 5 mmol per
            single dose)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Salicylic acid and its salts (in topical preparations in
            concentrations over 40%)
          </td>
        </tr>
        <tr>
          <td align="right" colname="c1" valign="top">2</td>
          <td colname="c2" valign="top">
            Sodium chloride (single ingredient solutions in concentrations of
            more than 0.9%)
          </td>
        </tr>
      </tbody>
    </table>
  </body>
</html>
